Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
While semaglutide programs for weight loss initially work, once someone stops taking the drug, Crannage said there is an abundance of data regarding people who have regained their weight
As long as you adhere to what your coach recommends, youll likely see the results you had hoped for
Directly Contacting Blue Cross Blue Shield Calling the customer service number on the back of your Blue Cross Blue Shield insurance card is a straightforward way to get information